8-K filing — Bunge Global SA (BG)
Filed: 2026-09-21 AccNo: 0001628280-26-062880 Size: 155 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
- Reuters
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-21 AccNo: 0001628280-26-062880 Size: 155 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Bunge Global (BG) benefits from strong soybean and softseed processing gains and Viterra integration with increased cost-synergy targets to $350 million. However, weak cash conversion, below-benchmark returns on invested capital, and persistent grain merchandising weakness create execution risks. The stock trades above its five-year median valuation, making synergy delivery and earnings consistency critical to investment thesis.
UBS analyst Manav Gupta maintains Bunge Global (NYSE:BG) with a Buy and raises the price target from $145 to $155.